Breakthrough infections and waning immune responses with ChAdOx1 nCoV-19 or mRNA vaccine in healthcare workers

Clin Transl Med. 2022 Apr;12(4):e804. doi: 10.1002/ctm2.804.

Authors

So Yun Lim¹, Jiwon Jung^{1

2}, Ji Yeun Kim¹, Soonju Park³, Ji-Soo Kwon¹, So Yeon Park², Sun-Kyung Kim², Young-Ju Lim², Eun Ok Kim², Seongman Bae¹, Min Jae Kim¹, Yong Pil Chong¹, Sang-Oh Lee¹, Sang-Ho Choi¹, Yang Soo Kim¹, Nakyung Lee³, Kideok Kim³, David Shum³, Youngmee Jee³, Sung-Han Kim^{1

2}

Affiliations

¹ Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
² Office for Infection Control, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
³ Institut Pasteur Korea, Seongnam-si, Republic of Korea.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 Vaccines*
ChAdOx1 nCoV-19*
Health Personnel
Humans
Immunity
Vaccines, Synthetic
mRNA Vaccines

Substances

COVID-19 Vaccines
Vaccines, Synthetic
mRNA Vaccines
ChAdOx1 nCoV-19